NRC Health (NRC)
NASDAQ: NRC · Real-Time Price · USD
19.51
+0.60 (3.17%)
Jul 31, 2026, 4:00 PM EDT - Market closed
NRC Health Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 140 | 137.39 | 143.06 | 148.58 | 151.57 | 147.95 |
Revenue Growth | -0.23% | -3.96% | -3.72% | -1.97% | 2.44% | 11.01% |
Gross Profit Gross Profit Growth | 86.45 | 85.02 | 86.13 | 92.57 | 94.52 | 95.6 |
Operating Income Operating Income Growth | 14.74 | 22.59 | 35.19 | 40.05 | 46.54 | 50.27 |
Net Income Net Income Growth | 5.86 | 11.6 | 24.78 | 30.97 | 31.8 | 37.47 |
Earnings Per Share EPS Growth | 0.25 | 0.50 | 1.04 | 1.25 | 1.27 | 1.46 |
EPS Growth | -67.11% | -51.92% | -16.80% | -1.57% | -13.01% | 0.69% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3.33 | 4.14 | 4.23 | 6.65 | 25.03 | 54.36 |
Total Debt Total Debt Growth | 90.03 | 79.04 | 62.68 | 36.68 | 22.18 | 26.55 |
Net Cash (Debt) Net Cash Growth | -86.7 | -74.9 | -58.45 | -30.03 | 2.85 | 27.81 |
Net Cash Growth | - | - | - | - | -89.77% | 581.38% |
Net Cash Per Share Net Cash Per Share Growth | -3.95 | -3.34 | -2.46 | -1.22 | 0.11 | 1.08 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 29.51 | 26.45 | 34.63 | 38.11 | 36.27 | 46.34 |
Capital Expenditures CapEx Growth | -7.87 | -10.71 | -15.45 | -15.78 | -9.84 | -5.51 |
Free Cash Flow Free Cash Flow Growth | 21.64 | 15.74 | 19.18 | 22.33 | 26.43 | 40.83 |
Free Cash Flow Growth | 133.40% | -17.90% | -14.13% | -15.50% | -35.27% | 11.40% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 61.75% | 61.88% | 60.20% | 62.30% | 62.36% | 64.62% |
Operating Margin | 10.53% | 16.44% | 24.60% | 26.95% | 30.71% | 33.98% |
Pretax Margin | 6.70% | 12.99% | 22.85% | 26.90% | 28.25% | 32.86% |
Profit Margin | 4.19% | 8.44% | 17.32% | 20.84% | 20.98% | 25.32% |
FCF Margin | 15.46% | 11.46% | 13.40% | 15.03% | 17.44% | 27.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.640 | 0.520 | 0.480 | 0.480 | 0.840 | 0.480 |
Dividend Per Share Growth | 33.33% | 8.33% | 0% | -42.86% | 75.00% | 128.57% |
Dividend Yield | 3.28% | 2.61% | 2.74% | 3.75% | 2.25% | 0.87% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 81.16 | 37.54 | 16.96 | 31.65 | 29.37 | 28.44 |
Forward PE | 20.54 | 34.39 | 34.39 | 34.39 | 34.39 | 34.39 |
P/FCF Ratio | 19.96 | 26.99 | 21.23 | 42.90 | 34.76 | 25.79 |
PS Ratio | 3.09 | 3.09 | 2.85 | 6.45 | 6.06 | 7.12 |